Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / GMAB - AbbVie: The Most Undervalued Income Stock


GMAB - AbbVie: The Most Undervalued Income Stock

Thesis Summary

AbbVie Inc. (ABBV) seems, on the surface, like an incredibly undervalued stock offering a 4.75% dividend yield with a payout ratio of under 50%. Upon further inspection though, it becomes clear that due to is dependence on HUMIRA, its best days may be behind it. Still, considering the dividend and growth prospects, I rate AbbVie a strong buy with a price target of $135 according to my 10-year DCF valuation.

Source: Siemens Digital Industries Software

Company Overview

ABBV is a pharmaceutical company operating worldwide. The company develops and commercializes drugs, of

Read more ...

Stock Information

Company Name: Genmab A/S
Stock Symbol: GMAB
Market: NASDAQ
Website: genmab.com

Menu

GMAB GMAB Quote GMAB Short GMAB News GMAB Articles GMAB Message Board
Get GMAB Alerts

News, Short Squeeze, Breakout and More Instantly...